Brexanolone and related neurosteroid GABA(A) positive allosteric modulators for postnatal depression

Claire A. Wilson*, Lindsay Robertson, Jennifer Valeska Elli Brown, Karyn Ayre, Hind Khalifeh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of brexanolone and related neurosteroid GABAA positive allosteric modulators in comparison with any other treatment (pharmacological, psychological, or psychosocial), placebo, or treatment as usual for postnatal depression (PND).

Original languageEnglish
Article numberCD014624
JournalCochrane Database of Systematic Reviews
Volume2021
Issue number5
DOIs
Publication statusPublished - 19 May 2021

Fingerprint

Dive into the research topics of 'Brexanolone and related neurosteroid GABA(A) positive allosteric modulators for postnatal depression'. Together they form a unique fingerprint.

Cite this